Home > Insider Trading > Filing (0001140361-15-010596)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1048477	Biomarin Pharmaceutical Inc	BMRN	Pharmaceutical Preparations (2834)	680397820

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1274826	Robert Baffi	C/O Biomarin Pharmaceutical Inc. 770 Lindaro St. San Rafael CA 94901	Evp, Technical Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-03-03	10,500	$0.00	109,700	No	4	A	Direct
Common Stock	Acquisiton	2015-03-05	11,000	$17.86	120,700	No	4	M	Direct
Common Stock	Acquisiton	2015-03-05	3,051	$14.39	123,751	No	4	M	Direct
Common Stock	Disposition	2015-03-05	14,051	$116.37	109,700	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy) Common Stock	Acquisiton	2015-03-03	23,900	$0.00	23,900	$108.36
Common Stock	Stock Option (right to buy) Common Stock	Disposition	2015-03-05	11,000	$0.00	11,000	$17.86
Common Stock	Stock Option (right to buy) Common Stock	Disposition	2015-03-05	3,051	$0.00	3,051	$14.39

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
23,900	2015-09-03	2025-03-02	No	4	A	Direct
0	2009-06-17	2018-12-16	No	4	M	Direct
0	2009-11-12	2019-05-11	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	23,935	Indirect	Shares held by Baffi Family Trust

Footnotes

Restricted stock units granted on March 3, 2015. Price not applicable.
The price in column 4 is a weighted average price. The price actually received ranged from $116.30 to $116.44. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the amount of shares sold at each price within the range.
Option grant vests 6/48ths on September 3, 2015, and 1/48th on the 3rd day of every month thereafter.
Option grant vests 6/48ths on June 17, 2009 and 1/48th on the 17th of every month thereafter.
Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.
Option grant vests 6/48ths on November 11, 2009 and 1/48th on the 11th of every month thereafter.